Home
Emcure Pharmaceuticals Ltd Share Price History
Emcure Pharmaceuticals Ltd
NSE : 02 Apr, 2025
1054.75-21.3 (-2.0%)
Prev Close
1076.1
Open Price
1081.2
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
65548
Today's High / Low
1089.9 / 1048.0
52 WK High / Low
1580.0 / 911.0
Market Price of Emcure Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2018 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 9.63 |
| YoY Gr. | - |
| Net Profit (Cr.) | 174 |
| BVPS | 94.05 |
Key Financial Parameters
| Parameter | 2010 |
|---|---|
| Return on Capital Emp. % | 19.71 |
| Op. Profit Mgn % | 20.48 |
| Net Profit Mgn % | 4.53 |
| Debt to Equity % | 1.5 |
Latest Shareholding
Promoters Holdings Over Time
About Emcure Pharmaceuticals Ltd
- Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
- Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
- They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.
Popular Search
FAQs for Emcure Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Emcure Pharmaceuticals Ltd's share price history?
Key events that impact Emcure Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Emcure Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Emcure Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Emcure Pharmaceuticals Ltd?
Dividends can influence Emcure Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Emcure Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Emcure Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Emcure Pharmaceuticals Ltd’s share price history?
To understand Emcure Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
